Public Citizen will push to get Crestor (rosuvastatin) off the market

April 2004

The consumer group, Public Citizen will push to get Crestor (rosuvastatin) off the market.

They say it causes renal failure and rhabdomyolysis.

Public Citizen has a track record worth noticing. They successfully went after phenylpropanolamine and the quinolone trovafloxacin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Canadian Hypertension Education Program Recommendations will reinforce many practice trends
Men's Health Levitra (vardenafil) just got approved by Health Canada
Men's Health using testosterone for "male menopause"
Cholesterol whether cholesterol needs to go even lower than previously thought for some patients
Cholesterol Public Citizen will push to get Crestor (rosuvastatin) off the market
Pediatrics Prevacid (lansoprazole) is the first proton pump inhibitor to be approved for use in kids
Dermatology best treatment for toenail fungus
Some antipsychotics seem to increase the risk of stroke in elderly patients with dementia
Natural Medicines whether coenzyme Q10 (ubiquinone) should be recommended for patients taking statins
Hematology & Oncology More women with breast cancer will be switched from tamoxifen to one of the aromatase inhibitors
People often ask what works for nighttime leg cramps
Women's Health Gynazole-1 reduces symptoms of vaginal yeast infection faster than the 7-day products
Women's Health the risks for women taking estrogen (Premarin) ALONE
Storage & Disposal Patients often ask how to dispose of unused or expired meds